Related Experiment Video
Updated: May 24, 2026
Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
Published on: June 23, 2023
Tissue-specific alterations of PRL-1 and PRL-2 expression in cancer
Abstract:
The PRL-1 and PRL-2 phosphatases have been implicated as oncogenic, however the involvement of these molecules in human neoplasms is not well understood. To increase understanding of the role PRL-1 and PRL-2 play in the neoplastic process, in situ hybridization was used to examine PRL-1 and PRL-2 mRNA expression in 285 normal, benign, and malignant human tissues of diverse origin. Immunohistochemical analysis was performed on a subset of these. PRL-1 and PRL-2 mRNA expression was also assessed in a small set of samples from a variety of diseases other than cancer. Where possible, associations with clinicopathological characteristics were evaluated. Alterations in PRL-1 or -2 expression were a frequent event, but the nature of those alterations was highly tumor type specific. PRL-1 was significantly overexpressed in 100% of hepatocellular and gastric carcinomas, but significantly under-expressed in 100% of ovarian, 80% of breast, and 75% of lung tumors. PRL-2 expression was significantly increased in 100% of hepatocellular carcinomas, yet significantly downregulated in 54% of kidney carcinomas. PRL-1 expression was correlated to patient gender in the bladder and to patient age in the brain and skeletal muscle. PRL-1 expression was also associated with tumor grade in the prostate, ovary, and uterus. These results suggest a pleiotropic role for PRL-1 and PRL-2 in the neoplastic process. These molecules may associate with tumor progression and serve as clinical markers of tumor aggressiveness in some tissues, but be involved in inhibition of tumor formation or growth in others.
Insights
Protein tyrosine phosphatases PRL-1 and PRL-2 show varied expression in human cancers. Their roles in neoplasms are tumor-specific, acting as oncogenes or tumor suppressors, and may serve as prognostic markers.
Area of Science:
- Molecular Biology
- Oncology
- Human Pathology
Background:
- The roles of PRL-1 and PRL-2 phosphatases in human neoplasms are not fully understood, despite their suspected oncogenic potential.
- Understanding the expression patterns of PRL-1 and PRL-2 in various human tissues is crucial for elucidating their involvement in cancer development.
Purpose of the Study:
- To investigate the mRNA expression of PRL-1 and PRL-2 in a wide range of normal, benign, and malignant human tissues.
- To correlate PRL-1 and PRL-2 expression with clinicopathological characteristics in different tumor types.
- To explore the potential of PRL-1 and PRL-2 as biomarkers in human neoplasms.
Main Methods:
- In situ hybridization was employed to examine PRL-1 and PRL-2 mRNA expression across 285 diverse human tissue samples.
- Immunohistochemical analysis was performed on a subset of these tissues.
- Expression levels were also assessed in non-cancerous diseases, and associations with clinicopathological features were evaluated.
Main Results:
- Alterations in PRL-1 and PRL-2 expression were frequent but highly tumor-specific.
- PRL-1 was overexpressed in hepatocellular and gastric carcinomas, but underexpressed in ovarian, breast, and lung tumors.
- PRL-2 was upregulated in hepatocellular carcinomas and downregulated in kidney carcinomas. Expression correlated with patient age, gender, and tumor grade in specific tissues.
Conclusions:
- PRL-1 and PRL-2 exhibit pleiotropic roles in the neoplastic process, with context-dependent functions.
- These phosphatases may be associated with tumor progression and aggressiveness in certain cancers.
- Conversely, they might inhibit tumor formation or growth in other tissue types, suggesting complex regulatory functions.
